These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7167420)

  • 1. Satietin: a centrally acting potent anorectic substance with a long-lasting effect in human and mammalian blood.
    Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):3-16. PubMed ID: 7167420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Satietin, a blood-borne, highly selective and potent anorectic glycoprotein.
    Knoll J
    Biomed Biochim Acta; 1985; 44(2):317-28. PubMed ID: 3890846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selectivity of the anorectic effect of satietin. II. Ineffectiveness of satietin on the water intake in food deprived rats. Effect of satietin in "conditioned aversion" paradigm.
    Sándor G; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):25-32. PubMed ID: 7167419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Satietin; a 50,000 dalton glycoprotein in human serum with potent, long-lasting and selective anorectic activity.
    Knoll J
    J Neural Transm; 1984; 59(3):163-94. PubMed ID: 6376708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Satietin, a blood-borne glycoprotein in the regulation of food intake.
    Knoll J
    Prog Clin Biol Res; 1985; 192():515-22. PubMed ID: 4080718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selectivity of the anorectic effect of satietin. III. The ineffectiveness of satietin on metabolic rate, body temperature and blood pressure.
    Timár J; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):33-9. PubMed ID: 7167421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Satietin, a blood-borne anorectic glycoprotein, as the putative rate-limiting satiety signal in the negative feed-back of food intake.
    Knoll J
    Z Ernahrungswiss; 1984 Jun; 23(2):85-103. PubMed ID: 6475142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selectivity of the anorectic effect of satietin. IV. The ineffectiveness of satietin on the sexual performance of male CFY rats.
    Yen TT; Dalló J; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):41-5. PubMed ID: 6984758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The selectivity of the anorectic effect of satietin. I. The ineffectiveness of satietin on behavioral tests.
    Knoll B; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):17-23. PubMed ID: 7167418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The time-structure of the anorectic effect of satietin.
    Sándor G; Knoll J
    Physiol Behav; 1985 May; 34(5):851-3. PubMed ID: 4034724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An improved method for the preparation of highly purified satietin samples from human serum.
    Nagy J; Kalàsz H; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(1-3):47-52. PubMed ID: 7167422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of the anorectic agent satietin from bovine serum.
    Nagy J
    Pharmacol Biochem Behav; 1994 May; 48(1):17-22. PubMed ID: 8029288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution to characterization of anorectic protein similar to satietin from urine.
    Maletínská L; Slaninová J
    Pharmacol Biochem Behav; 1995 Dec; 52(4):715-21. PubMed ID: 8587910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of continuous intracerebroventricular infusion of satietin on ingestion, activity and body weight of rats.
    Bellinger LL; Mendel VE
    Physiol Behav; 1987; 41(5):505-9. PubMed ID: 3432407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic tripeptides with anorexogenic effect.
    Szirtes T; Knoll B; Kisfaludy L; Knoll J
    Pol J Pharmacol Pharm; 1982; 34(5-6):339-45. PubMed ID: 6821217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satietin: route of injection, dose response, effect on food and water intake and on running-wheel activity in the rat.
    Mendel VE; Bellinger LL; Williams FE; Iredale RA
    Pharmacol Biochem Behav; 1986 Feb; 24(2):247-51. PubMed ID: 3952114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intracerebroventricularly infused satietin on conditioned taste aversion and feeding in rats fasted different lengths.
    Bellinger LL; Mendel VE
    Pharmacol Biochem Behav; 1985 Oct; 23(4):559-66. PubMed ID: 4070333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HPLC-purified human satietin does not produce conditioned taste aversion in rats.
    Bellinger LL; Mendel VE
    Pharmacol Biochem Behav; 1991 May; 39(1):161-5. PubMed ID: 1924498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.